Comparison of the Systemic Effects of Local Anesthesia with and without Epinephrine in Children by Swanson, Robert A.
Loyola University Chicago
Loyola eCommons
Master's Theses Theses and Dissertations
1980
Comparison of the Systemic Effects of Local
Anesthesia with and without Epinephrine in
Children
Robert A. Swanson
Loyola University Chicago
This Thesis is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in
Master's Theses by an authorized administrator of Loyola eCommons. For more information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 1980 Robert A. Swanson
Recommended Citation
Swanson, Robert A., "Comparison of the Systemic Effects of Local Anesthesia with and without Epinephrine in Children" (1980).
Master's Theses. Paper 3077.
http://ecommons.luc.edu/luc_theses/3077
COMPARISON OF THE SYSTEMIC EFFECTS OF LOCAL ANESTHESIA 
WITH AND WITHOUT EPINEPHRINE IN CHILDREN 
BY 
Robert A. Swanson, D.D.S. 
A Thesis Submitted to the Faculty of the Graduate School 
of Loyola University of Chicago in Partial Fulfillment 
of the Requirements for the Degree of 
Master of Science 
June 
1980 
... , ~--- ~. --· \ 
ACKNOWLEDGMENTS 
My sincere gratitude and appreciation to the following: 
To Priscilla Bourgault, Ph.D., associate professor of Physi-
ology/Pharmacology, my teacher and advisor, for her untiring guidance 
and support in preparing this thesis. 
To Eugene Grandel, D.D.S., M.S., Chairman of the Department of 
Pedodontics, for his advice in planning the clinical aspects of this 
study. 
To Wayne E. Milos, D.D.S., M.S., Assistant Professor of the 
Department of Pedodontics and Director of Post-graduate Pedodontics, 
for his technical and clinical assistance in preparing this thesis. 
To the dental students in the Classes of 1976 and 1977 for al-
lowing me the use of their pedodontic patients. 
To Loyola University for making all of this possible. 
ti 
VITA 
The author, Robert A. Swanson, is the son of Dr. Adrian L. 
Swanson and Margaret A. Swanson. He was born April 5, 1950, in 
Evanston, Illinois. 
His elementary education was obtained in the public schools 
of Wilmette, Ill., and secondary education at New Trier Township 
High School, Winnetka, Ill., where he graduated in 1968. In 
September, 1968, he entered the University of Colorado and in May, 
1973, received the degree of Bachelor of Arts in biology. 
In September, 1973, he was employed as a biologist with the 
Florida State Department of Natural Resources, Bureau of Aquatic 
Plants. In September, 1974, he enrolled in the Loyola University 
of Chicago Graduate School and in September, 1976, entered the 
Loyola University Dental School where he graduated in May, 1980. 
iii 
ACKNOWLEDGEMENTS .• 
VITA. . • . • . • • • 
LIST OF TABLES •• 
LIST OF FIGURES ••• 
INTRODUCTION. • • 0 • 
TABLE OF CONTENTS 
. . . . . 
• • • • • 0 • • • • • • • • • 
. . . . . . 
REVIEW OF RELATED LITERATURE •• . . . 
Secretion and Elimination of Epinephrine •• 
Adrenergic Receptor Sites ••• 
Epinephrine in Local Anesthesia • • •• 
Galvanic Skin Response ••••••••••• 
METHODS AND MATERIALS • • • • . . . . . . . . . 
. . . . . . 
Selection of Patients • 
Personnel •.••••••• 
. . . . . . . . . . . 
. . . 
Anesthetic Solutions. • ••• 
Recording Equipment • • • • • • • • • • • • . • • ••• 
Experimental Method and Recording Procedure • • • 
EXPERIMENTAL RESULTS .• . . . . 
Heart Rate •••••••• 
Blood Pressure •••••• 
Galvanic Skin Response •• 
• • • 0 • • ' 
. . . . . . . . . . . 
DISCUSSION .•••.••• 
SUMMARY AND CONCLUSIONS • 
BIBLIOGRAPHY ••••••• 
. . . . . . . . . . . . 
. . . . . . . . 
iv 
. . . . . 
. . . . 
Page 
ii 
i; i 
v 
vi 
1 
2 
2 
2 
4 
9 
11 
11 
11 
12 
12 
12 
16 
16 
16 
20 
31 
34 
35 
LIST OF TABLES 
Table Page 
I. HEART RATE 
2% Xylocaine without epinephrine. • • 0 • • c • • • • 0 • 17 
II. HEART RATE 
2% Xylocatne with epinephrine ••• • • • • • • • • • • 0 18 
III. HEART RATE 
Comparison of 2% Xylocaine with or 
without epinephrine at different time intervals • • • • • 19 
IV. SYSTOLIC BLOOD PRESSURE 
2% Xylocaine without epinephrine. . . . . . . . . . . . . 21 
v. SYSTOLIC BLOOD PRESSURE 
2% Xylocaine with epinephrine •• . . . . . . . . . . . . 22 
VI. SYSTOLIC BLOOD PRESSURE 
Comparison of 2% Xylocaine with or without epinephrine 
at different time intervals • • • • • • • • • • • • • • • 23 
VII. DIASTOLIC BLOOD PRESSURE 
2% Xylocaine without epinephrine. . . . . . . . . . . . . 24 
VIII. DIASTOLIC BLOOD PRESSURE 
2% Xylocaine with epinephrine •• • • 0 • • • • • • • • 0 25 
IX. DIASTOLIC BLOOD PRESSURE 
Comparison of 2% Xylocaine with or without epinephrine 
at different time intervals • • • • • • • • • • • • • • • 26 
X. GALVANIC SKIN RESPONSE 
Comparison of 2% Xylocaine with or without epinephrine 
at different time intervdls • • • • • • • • . • • • • • • 28 
v 
LIST OF FIGURES 
Page 
Figure 
I. Comparison of Parameters Using the Same Time Scale. • • . • 32 
vi 
INTRODUCTION 
In 1924 Braun first introduced the use of the vasoconstrictor 
in local anesthetic solutions because procaine was found to be short 
acting due to rapid diffusion. He found that the addition of minute 
amounts epinephrine (1:100,000-1:200,000) resulted in longer lasting 
and more satisfactory anesthetic properties. 
Since that time there has been concern over the cardiovascular 
effects produced by epinepherine. Several studies have been con-
ducted to determine whether this concern is warranted. The subjects 
for these studies, however, have all been adults (normotensive, hy-
pertensive, and those with cardiac disease). No studies concerning 
epinephrine have utilized children as subjects. It would seem that 
children, due to their smaller size and different metabolic rates, 
might be more susceptible to the effects of epinepherine when in-
jected with the same or slightly smaller doses. It is the intent 
of this study to monitor blood pressure, heart rate, and galvanic 
skin response for changes caused by the addition of epinephrine to 
a local anesthetic solution and to determine which anesthetic solu-
tion is most comfortable and effective for use with children. 
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REVIEW OF RELATED LITERATURE 
Secretion~ Elimination of Epinephrine 
Epinephrine is normally secreted by the resting adrenal medulla 
at the rate of approximately 0.2 mg/kg/min. (Guyton, 1976). It is 
rapidly metabolized by catechol-0-methyl-transferase and monoamine-
oxidase in various tissues of the body (mainly the liver) and the 
metabolic products are excreted through the kidneys. A dose of 0.1 
mg./kg. of epinephrine given intravenously is completely metabolized 
within ten minutes and smaller doses in less time. The biological 
half-life for epinephrine is less than one minute (Glover, 1968). 
Under normal resting conditions, the catecholamine concentra-
tion (primarily epinephrine) is 0.1-1.0 micrograms/liter of blood. 
With pain, excitement, anxiety, anoxia, or similar stresses, the con-
centration increases to as much as 100 micrograms/liter of blood (Sel-
kurt, 1971). Under these conditions, all properties of the heart are 
stimulated, including pulse rate, automaticity, excitability, and con-
tractility. Also apparent are increased cardiac output, a rise in 
blood pressure, and increased metabolism (Manheim, 1966). 
Adrenergic Receptor Sites 
In 1948 Ahlquist proposed the existence of two types of adrener-
gic receptors which he designated "alpha" and 11 beta 11 • He proposed 
that the activation of alpha receptors by an adrenergic drug caused 
one type of response and the activation of beta receptors caused a 
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different response. The action of alpha receptors is generally ex-
citatory on smooth muscle. The exception to this statement is that 
alpha receptors in the gastrointestinal tract produce intestinal re-
laxation when stimulated. Excitation of beta receptors is usually 
inhibitory to smooth muscle and excitatory to cardiac muscle. 
Most tissues have both alpha and beta receptors. The response 
of a certain tissue depends primarily on the majority of the receptor 
types present. For example, smooth muscle of blood vessels in the 
skin and mucosa exhibits primarily alpha receptors and, thus, responds 
to epinephrine with vasoconstriction. Smooth muscle of blood vessels 
in skeletal muscle has a majority of beta receptors and responds to 
epinephrine with vasodilation. The receptors in the heart are of the 
beta type and respond with increased heart rate and strength of con-
traction (Holroyd, 1974). 
Goodman and Gilman (1975) state that 1.5-1.0 mg. of epinephrine, 
injected subcutaneously (or .Ol-.03 micrograms, intravenous infusion), 
may cause cardiac output to increase but, due to dilation in some blood 
vessels (a decrease in peripheral vascular resistance), blood pressure 
is usually not greatly elevated. This is primarily due ~to the greater 
sensitivity to epinephrine of beta receptors in vascular beds dilated 
by the drug than of alpha receptors in vascular beds constricted by it" 
(Goodman and Gilman, 1970). Their fifth edition (1975) states that 
"diastolic blood pressure usually falls" with subcutaneous doses as 
large as 0.5-1.5 mg. 
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Ordinarily the vasodilator effect of epinephrine dominates the 
circulation, and the rise in systolic pressure is largely due to an 
increased cardiac output. With increasing dosages there may be no 
change or even a rise in peripheral resistance and diastolic pres-
sure which is attributed to the increased participation of alpha re-
ceptors when compared to beta receptors in various vascular beds. 
Epinephrine~ Local Anesthesia 
There are two schools of thought concerning the use of epineph-
rine in local anesthesia. The first is concerned with the physiolog-
ical changes produced by exogenous epinephrine, particularily in hy-
pertensive patients and patients with cardiovascular disease. 
In an early investigation, Miller et al., (1938) subjected 26 
patients (13 subjects and 13 controls), aged 16-70, to mandibular 
blocks and reported minor changes in heart rhythm and in the T waves 
of the electrocardiogram when using 2-9 cc. of 2% procaine with 
1:50,000 (.04-.18 mg.) epinephrine. A higher concentration of epi-
nephrine, 1:20,000 (.08-.4 mg.), produced greater T wave changes while 
Ringer's solution produced no changes. 
When a solution containing epinephrine is intravenously infused 
tnto a normal adult at such a rate that the patient receives about 
.01-.02 mg./min. for three minutes, the following hemodynamic changes 
will generally be observed: systolic pressure increases, diastolic 
pressure decreases, mean pressure remains unchanged, and cardiac out-
put increases approximately 5-6 minutes after infusion (Barcroft, 1949). 
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White (1952) states that 0.5 mg. of epinephrine is the effec-
tive dose for pressor effects in normal adults when injected subcu-
taneously. 
McCarthy (1957) studied cardiovascular changes in 40 male sub-
jects, aged 21-32, using 5cc. of 2% procaine with and without 1:50,000 
epinephrine (.1 mg), 2% lidocaine with and without 1:100,000 epineph-
rine (.05 mg), an isotonic saline solution, and a pseudoinjection for 
a control. These solutions were deposited at buccal and palatine in-
jection sites. He reported no pressor responses but noted a signifi-
cant fall in diastolic pressure during the 10 minutes after injection 
which he attributed to the depressing effect of small amounts of exo-
genous epinephrine causing a decrease in peripheral resistance. 
Kennedy (1966) demonstrated major cardiovascular changes on 30 
adult patients (15 subjects and 15 controls) with doses of epinephrine 
ranging from ,025 to .4 mg. in the brachial plexus and epidural blocks. 
These changes included significant decreases in mean arterial pressure, 
increases in heart rate, increases in cardiac output, and decreases in 
peripheral resistance. 
Using 2% Lignocaine (lidocaine) with 1:80,000 epinephrine (mean 
injected volume of 5.9 ml. (about .08 mg.) on adult subjects undergoing 
oral surgery, Aellig (1970) found an increase of between 5 and 40 beats/ 
min. in the pulse rate of all 27 subjects. In a similar experiment, 
Persson (1969} reported that 10% of his subjects experienced electro-
cardiographic changes and/or other side effects. 
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Allen et al., (1973) used 1.8 ml. of 2% lidocaine with and with-
out 1:100,000 (.018 mg.) epinephrine for inferior alveolar nerve blocks 
on subjects between 21 and 38 years of age. He found no changes in 
the mean arterial pressure or pulse rate but, using Jorgenson and Shane 
techniques, did find a rise in stroke volume 5 and 15 minutes after in-
jection and a fall in diastolic blood pressure due to decreased periph-
eral resistance. Allen did not substantiate conclusions that fear and 
anxiety produced greater changes in cardiorespiratory effects than ex-
ogenous epinephrine. 
The second school of thought believes that the amounts of epin-
ephrine used in local dental anesthesia are too small to be of physio-
logical importance. Furthermore, these small amounts of epinephrine 
provide a longer period of anesthesia. Dental anesthesia produced 
with 2% lignocaine hydrochloride lasts about 20 minutes, but the ad-
dition of 1:80,000 (about .015 mg.) epinephrine prolongs the effects 
to an hour and a half or more (British Medical Journal, 1970 and 
Gangarosa, 1967}. 
Bjorn and Hullet (1947) found an increased efficiency of anes-
thesia with increased epinephrine (1:40,000 or .02 mg./cc.) for 1% 
lidocaine. Gangarosa (1967), however, reported no clinical advantage 
between 1:100,000 (.01 mg./cc.) and 1:300,000 (.004 mg./cc.) epineph-
rine in lidocaine solutions. 
Wallace et al., (1956) investigated the difference in the cardio-
vascular system resulting from the use of 2.1 cc of 2% procaine with 
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and without 1:50,000 (.02 mg./cc.} epinephrine. Using 19 healthy stu-
dents, Wallace and coworkers took automatic continuous recordings of 
finger plethysmography, pneumography, unipolar frontal and occipital 
electro encephalograms, and standard electrocardiogram determinations. 
Systolic and diastolic pressures were measured with a cuff at two 
minute intervals. Their conclusions were that there were no clini-
cally significant systemic cardiovascular changes. 
Cheraskin (1958} reported, under simulated office procedures, 
that there was little variation in systolic, diastolic, mean, and 
pulse pressures and in pulse rate at 5 and 10 minute intervals after 
injection of 2 to 8 cc. of 2% lidocaine with and without 1:100,000 
(.02-.08 mg.) epinephrine in 136 normotensive and hypertensive pa-
tients. In a study on 142 sedated hypertensive patients, Cheraskin 
(1959} found that 2% lidocaine with epinephrine produced less cardio-
vascular effects than lidocaine without epinephrine. 
Elliot and Stein (1974), using 40 patients aged 39-78 with his-
tories of atherosclerotic heart disease, found no significant differ-
ences in blood pressure, heart rate, and electrocardiograms 1, 5, and 
10 minutes after injection of 1.8 cc of 2% lidocaine hydrochloride 
with and without 1:50,000 (.04 mg.) epinephrine. 
The New York Heart Association states that 0.2 mg. of epineph-
rine is the maximum total dosage for cardiac patients (Holroyd, 1960). 
The opinion expressed in Accepted Dental Therapeutics (1977) is that 
concern over the small amounts of epinephrine in local anesthetic 
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solutions used for dentistry is unwarranted. 
Holroyd (1960) states that the cardiovascular effects of epineph-
rine in local anesthesia have been subject to many investigations which 
concluded that inadequate local anesthesia would cause the production 
of more endogenous epinephrine than the quantity injected. Emotional 
stresses such as pain, fear, and anxiety produce a natural secretion 
of epinephrine into the blood and this quantity is much greater than 
that found in the average dental anesthetic (Orringer, 1949; Dick, 
1953). Several investigators state that local anesthetic solutions 
without a vasoconstrictor are not satisfactory because the likelihood 
of pain is much greater due to their uncertain or incomplete anesthesia 
(Tainter, 1940; Orringer, 1949; Dick, 1953; and Brown, 1968). 
The British Medical Journal (1970) concludes that so long as 
local anesthetics containing vasoconstrictors are never used in the 
finger, toe, ear, or other areas of restricted circulation and are in-
jected subcutaneously in doses not exceeding .5 mg. they are largely 
free of risk and the more prolonged anesthesia produced greatly ex-
tends their usefulness. It also indicates that .025 mg. of epineph-
rine in a dental nerve block would be absorbed slowly over a 2 hour 
period into the circulation and no effects should be expected. 
In summary, although there is argument over the use of epineph-
rine in local dental anesthetic solutions, it appears that the disa-
greement is fundamentally based on the dosage and route of injection. 
Those studies that demonstrated systemic_cardiovascular changes were 
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were based on using subcutaneous routes with dosages ranging from .025 
to .4 mg. or on using intravenous routes with dosages as small as 
.01 - .02 mg. The other studies which did not demonstrate cardiovas-
cular changes used subcutaneous routes with dosages from .004 mg. to 
.08 mg. 
Galvanic Skin Response 
The galvanic skin response (GSR) is an indicator of emotional 
tension which has been used primarily in conjunction with the lie de-
tector. The measurement of the GSR is made by passing a small elec-
trical impulse across the skin between two electrodes. The electrical 
resistance of the skin to the impulse decreases as sweating increases 
and this, in turn, produces a deflection in the recording (Lewis and 
Law, 1958). 
Darrow (1970) believed that the GSR involves a number of events. 
Following excitation, sympathetic impulses to sweat glands and the sub-
sequent release of acetycholine account for the initial negative re-
sistance changes while the resistance is high (before sweating has 
reached a critical level). These impulses, however, initiate the chol-
inergic response of the sweat glands and, once started, sweating is the 
major factor contributing to the positive potential and large de-
creases in skin resistance. Since sweat glands receive cholinergic 
sympathetic innervation, they are not expected to be stimulated by cat-
echolamine (i.e. epinephrine)(Guyton, 1976; Goth, 1974}. According to 
Carmichael (1941), a decrease in skin resistance of 2500 ohms indicates 
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anxiety in subjects accustomed to a given testing procedure. 
Jones (1948) and Lacey (1952) have both demonstrated that it is 
possible to measure emotional changes in children by using electronic 
equipment to record the GSR. In his experiment, Lacey correlated GSR 
to heart rate and blood pressure responses to a given stress anc con-
cluded that the amount of response for each parameter varied for each 
child but was fairly consistent for a given child. 
Howitt and Striker (1965) studied the physiologic changes of 
children aged four to seven years during simulated dental appointments. 
They used a modified Stoeling polygraph to record the cardiac rate 
and peripheral blood flow. In their report, only the cardiac rate 
was considered. They did not report on the results of the GSR. 
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METHODS AND MATERIALS 
Selection of Patients 
The twelve subjects for this study were chosen from the Loyola 
Dental School Pedodontic Department with a random distribution of race 
and sex. The requirements for the children were that they l) had some 
previous experience in the dental situation, 2) were between four and 
ten years of age, 3} were not excessively hyperactive, and 4) required 
at least two visits to the clinic for similar procedures in the maxil-
lary arch. The parent or guardian of each child was asked to sign a 
standard consent form which explained the study and allowed them to 
withdraw their children at any time. 
The procedures for this study were limited to Class I or Class 
II amalgam restorations or stainless steel crowns on deciduous or 
permanent maxillary mola_rs. The maxillary arch was chosen over the 
mandibular arch because it was felt that anesthesia would be more uni-
form with regard to duration and quality if the anesthetic solutions 
were infiltrated as opposed to mandibular blocking (Grandel, 1975). 
No effort was made to distinguish between permanent and decicuous mo-
lars because the structure of the molar should have no effect on the 
nerves being anesthetized. 
Personnel 
The personnel for this study consisted of ten dental students 
and one investigator who was responsible for attaching the electrodes 
and pressor cuff to the child and operating the recording instrument. 
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The investigator remained in the cubicle throughout the procedure to 
make any necessary adjustments. Pedodontic instructors occasionally 
checked the dental student's progress as ts normally done in this 
clinic but remained no longer than was necessary. 
Anesthetic Solutions 
Anesthetic solutions in the form of 1.8 cc. carpules containing 
2% xylocaine hydrochloride with or without 1:100,000 epinephrine were 
furnished by Astra Pharmaceutical Products, Inc. 
Recording Eguipment 
Physiologic recording equipment utilized in this study was manu-
factured by E. and M. Instrument Company in Houston, Texas. Physic-
graph Four-A, a four channel polygraph, was used throughout the study 
with all four channels in operation. 
The electrosphygmograph, part no. 93-400071, recorded on channel 
one, the photoelectric pulse pickup, part no. 91-500-700, recorded on 
channel two, and the galvanic skin response preamplifier, part no. 
93-700-70, recorded on channel three. Channel four was used as a time 
and event marker. A children's size blood pressure cuff was used in 
conjunction with the electrosphygmograph and lead plate electrodes 
served as leads for the galvanic skin response. 
Experimental Method and Recording Procedure 
The child was ushered into the clinic by the dental student and 
was seated in the dental chair in the cubicle. The investigator im-
mediately attached the leads from the polygraph to the child, giving 
a simplistic explanation for each one and assuring the child that they 
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would cause no pain. The child was then asked not to move his hands 
or fingers because that would shake the wires and interfere with the 
recordings. 
The child then sat quietly for 5 to 10 minutes, neither en-
couraged nor discouraged from talking, while baseline recording levels 
were being established. Once the baselines were stable, the dental 
student was asked by the investigator to inject the anesthetic solu-
tion and to continue with the procedure, working at his/her own pace. 
Data was recorded continuously until the student was finished. 
Although the patient was uin a blind" as to the anesthetic solu-
tion, the dental student was not. The choice of solution was the in-
vestigator's responsibility. The child was given one half carpule 
(0.9 cc.) of xylocaine either with epinephrine (1:100,000) or without 
epinephrine on the first visit and which ever solution remained on the 
second visit. The dosage of epinephrine was .01 mg., injected subcu-
taneously into the mucobuccal fold. 
The physiologic parameters recorded in this study were heart rate, 
blood pressure, and galvanic skin response. Heart rate and galvanic 
skin response were recorded continuously throughout the procedure and 
blood pressure was taken at approximately five minute intervals. 
Heart rate was recorded with a photoelectric pulse pickup. This 
device is a plethysmographic transducer which detects and records the 
cardiovascular pulse pressure wave. It requires direct attachment to 
any vascular area; in this study, the left middle finger. The 
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transducer connects directly to the polygraph and requires no pream-
plification. The pulse sensing element consists of a photoconductor 
and a light source mounted side by side. The light source transil-
luminates the area to which it is applied and the photoconductor de-
tects changes in light intensity within the tissues caused by pulsa-
tile variations in blood volume. This change in the light intensity 
reaching the photoconductor causes a change in the electrical output 
which is amplified and transformed into mechanical energy to deflect 
the pen on the polygraph. 
Blood pressure was recorded by an electrosphygmograph which is 
a transducer/preamplifier for the recording of indirect systolic and 
diastolic blood pressures. It combines a pressure transducer and a 
preamplifier to produce single channel recordings of occluding cuff 
pressure and superimposed Korotkoff sounds. The electrosphygmograph 
was used in conjunction with a child-sized, wrap-around pressure cuff 
which was connected to an automatic cuff pump for blood pressure sam-
pling. Placement for the cuff was on the child's right arm. 
The galvanic skin response device is a transducer/preamplifier 
for recording the variations in skin resistance resulting from the 
reaction of the autonomic nervous system to internal and external 
stimuli. The skin response is obtained by measuring the resistance 
between two electrodes applied to the left index finger of the subject. 
A constant D.C. current of 20 microamperes is passed through the elec-
trodes, and the voltage across the electrodes is then amplified and 
14 
recorded on the polygraph. With the current held constant, the voltage 
across the electrodes is directly proportional to the resistance be-
tween the electrodes. This device can measure skin resistance up to 
1 ,000,000 ohms. 
The output of the galvanic skin response preamplifier recording 
equipment was recorded as a direct-coupled signal. In this way, the 
skin resistance of the subject was balanced out and read directly on 
the calibrated dial. The sensitivity for the preamplifier was set at 
10,000 ohms per centimeter of recording pen deflection. 
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EXPERIMENTAL RESULTS 
Heart Rate 
Heart rate was recorded for all experiments on the twelve sub-
jects. Statistical analyses were made for the following time periods; 
before injection (control), at injection, 5, 10, 15, 20, 30, and 45 
minutes after injection. Paired t-tests were utilized to determine 
1) statistical differences between each time period 
compared to the control (baseline level before in-
jection) for each anesthetic solution and 
2) statistical differences between each solution at 
each time period. 
Mean, standard deviation, mean difference (time period mean minus con-
trol mean), and p-values are presented in Tables I, II, and III. 
Statistically significant decreases in heart rate are noted at 
20, 30, and 45 minutes after injection without epinephrine (p<.Ol, 
p<.004, and p<.03, respectively). 
Statistically significant decreases in heart rate are noted at 
30 {p<.05) and 45 (p<.06) minutes after injection with epinephrine. 
No statistically significant differences are noted between the 
two drugs at any given time period. 
Blood Pressure 
Systoli~ and diastolic blood pressures were recorded for all 
experiments on the twelve subjects. Data was analyzed for the 
16 
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TABLE I 
HEART RATE 
2% Xylocaine 
without epinephrine 
Standard Mean 
Time Period Mean Deviation Diff. p-value 
Ts (before injection) 95.2 9.39 
To (injection) 97.1 7.28 -1.92 0.208 
T5 93.6 7. 72 1.58 0.420 
TlO 92.7 8.40 2.42 0.138 
T15 92.8 6.89 2.33 0.153 
T20 90.5 9.36 4.67 0.010* 
T30 91.3 8.19 3.83 0.004* 
T45 89.9 11.01 5.25 0.030* 
* Significant Values 
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TABLE II 
HEART RATE 
2% Xylocaine 
with epinephrine 
Standard Mean 
Time Period Mean Deviation Diff. p-value 
TB (before injection) 98.1 1 o. 76 
To (injection 99.4 11.67 -1.33 0.173 
T5 98.7 11.14 -0.58 0.589 
TlO 96.8 11.72 1.25 0.532 
T15 96.2 1 o. 06 1.83 0.242 
T2o 95.0 1 o. 24 3.08 0.112 
T30 93.5 1 o. 01 4.58 0.052* 
T45 94.2 8.35 3.91 0.065* 
* Significant Values 
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TABLE III 
HEART RATE 
Comparison of 2% Xylocaine 
with or without epinephrine 
at different time intervals 
Mean Standard 
Time Period Difference Deviation p-value 
TB (control) -2.92 9.65 0.318 
To -2.33 1 o. 45 0.455 
T5 -5.08 12.60 0.190 
TlO -4.08 10.33 0.198 
T15 -3.42 8. 71 0.202 
T20 -4.50 10.82 0.178 
T30 -2.17 10.37 0.484 
T45 -4.25 10.43 0.186 
following time periods; before injection (control), 5, 10, 15, 20, 30, 
and 45 minutes after injection. Paired t-tests were utilized to de-
termine 
1) statistically significant differences between each 
time period compared to the control (baseline level 
before injection} for each anesthetic solution and 
2) statistically significant differences between each 
solution at each time period. 
Mean, standard deviation, mean difference (time period mean minus con-
trol mean}, and p-values are presented in Tables IV, V, and VI for 
systolic blood pressure and Tables VII, VIII, and IX for diastolic 
blood pressure. 
Statistically significant increases in systolic blood pressure 
are noted at 45 minutes after injection without epinephrine (p<.035). 
No statistically significant changes are noted in systolic blood 
pressure after injection with epinephrine nor are any significant 
changes noted in diastolic blood pressure with either drug. 
No statistically significant differences between the drugs are 
noted for either systolic or diastolic blood pressure at any time 
period. 
Galvanic Skin Response 
GSR was recorded continuously for all experiments on the twelve 
subjects. Results were analyzed by means of a paired t-test at 30 
second intervals, starting one minute before injection (control) and 
20 
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TABLE IV 
SYSTOLIC BLOOD PRESSURE 
2% Xy1ocaine 
without epinephrine 
Standard Mean 
Time Period Mean Deviation Diff. p-value 
TB (before injection) 101.2 9.22 
T5 103.5 9.39 -2.25 0.112 
T1o 102.1 9.73 -0.83 0.558 
T15 103.0 10.29 -1.75 o. 191 
T2o 102.0 10.60 -0.75 o. 727 
T3o 104.0 12.74 -3.08 0.146 
T45 105.7 7.76 -4.58 0.035* 
* Significant Values 
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TABLE V 
. SYSTOLIC BLOOD PRESSURE 
2% Xy1ocaine 
with epinephrine 
Standard Mean 
Time Period Mean Deviation Diff. p-va1ue 
TB (before injection) 104.8 6.60 
T5 103.3 7.40 1.50 0.300 
T1o 102.7 8.80 2.08 0.297 
r,5 104.7 1 o. 55 0.08 0.973 
T20 103.7 7.18 1.17 0.538 
T30 103.2 7.34 1.58 0.350 
T45 103.0 6.88 1.83 0.403 
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TABLE VI 
SYSTOLIC BLOOD PRESSURE 
Comparison of 2% Xy1ocaine 
with or without epinephrine 
at different time intervals 
Mean Standard 
Time Period Difference Deviation p-value 
TB (control) -3.58 9.08 0.199 
T5 o. 17 9.81 0.954 
T10 -0.67 12.57 0.858 
T15 -1.75 11.99 0.623 
T20 -1.67 8.65 0.518 
T30 1.08 14.18 0.796 
T45 2.93 10.44 0.367 
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TABLE VII 
DIASTOLIC BLOOD PRESSURE 
2% Xylocaine 
without epinephrine 
Standard Mean 
Time Period Mean Deviation Diff. p-value 
TB (before injection) 66.0 6. 71 
T5 67.25 6.54 -1.25 0.150 
TlO 67.33 8.28 -1.33 0.333 
T15 67.25 9.06 -1.25 0.399 
T2o 66.58 8.84 -0.58 o. 720 
T30 68.25 8.93 -2.25 0.215 
T45 68.08 8.45 -2.08 o. 211 
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TABLE VIII 
DIASTOLIC BLOOD PRESSURE 
2% Xy1ocaine 
with epinephrine 
Standard Mean 
Time Period Mean Deviation Diff. p-va1ue 
TB (before injection) 64.92 3.48 
T5 65.42 4.91 -0.50 0.429 
TlQ 65.08 4.76 -0.17 0.854 
T15 64.08 4.67 0.83 0.475 
T2o 64.58 4.87 0.33 0.643 
T3o 64.42 5.12 0.50 0.687 
T45 65.25 3.67 -0.33 0.718 
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TABLE IX 
DIASTOLIC BLOOD PRESSURE 
Comparison of 2% Xylocaine 
with or without epinephrine 
at different time intervals 
Mean Standard 
Time Period Difference Deviation p-value 
TB (control) 1.08 6.54 0.578 
T5 1.83 5.87 0.303 
Tlo 2.25 9.24 0.417 
Tl5 3 017 11.15 0.346 
T20 2.00 9.33 0.473 
T30 3.83 8.85 0.162 
T45 2.83 8.34 0.264 
continuing to 25 minutes after injection, to determine statistical 
differences in GSR between the two solutions. Mean difference, stand-
ard deviation, and p-values are presented in Table X. 
The p-values show no significant differences in GSR as a result 
of these anesthetic solutions. 
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TABLE X 
GALVANIC SKIN RESPONSE 
Comparison of 2% Xylocaine 
with or without epinephrine 
at different time intervals 
Mean Standard 
Time Period Difference Deviation p-value 
T_,(control) o.o 0.0 1. 000 
T-0.5 0.08 5.07 0.955 
To (injection) -4.0 14.94 0.373 
To.5 -9.42 46.88 0.501 
T, -15.58 48.42 0.294 
Tl.5 -16.92 44.63 0.216 
T2 -9.83 43.35 0.449 
T2.5 -6.42 43.24 0.617 
T3 -5.42 43.38 0.674 
T3.5 -6.83 76.40 0.762 
T4 -11.16 77.28 0.627 
T4.5 -14.0 74.90 0.531 
T5 -0.25 80.67 0.992 
T5.5 0.33 79.41 0.989 
T6 1.00 79.85 0.966 
T6.5 -3.92 84.99 0.876 
T7 -7.16 87.25 0.781 
T7.5 -8.75 89.88 0.742 
T8 -11.92 89.49 0.654 
T8.5 -15.92 85.37 0.532 
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TABLE X (cont.) 
Mean Standard 
Time Period Difference Deviation p-value 
T9 -18.0 88.04 0.494 
T9.5 -18.58 87.70 0.478 
TlO -16.33 87.42 0.531 
Tl0.5 -14.42 82.09 0.555 
Tn -14.67 84.24 0.559 
Tn.5 -15.75 84.24 0.530 
T12 -17.33 81.52 0.477 
T12.5 -19.75 80.51 0.414 
T13 -23.5 87.10 0.370 
T13.5 -25.58 78.95 0.286 
T14 -34.33 80.73 0.169 
T14.5 -37.83 84.31 0.148 
T15 -39.0 93.21 o. 175 
T15.5 -39.25 91.81 0.167 
T16 -37.42 94.12 o. 196 
T16.5 -32.16 87.31 0.228 
Tl7 -28.75 78.74 0.232 
Tl7 .5 -25.33 90.50 0.353 
T18 -26.00 82.94 o. 301 
T18.5 -23.58 83.14 0.347 
T19 -32.08 88.46 0.235 
T19.5 -9.00 91.71 0.740 
30 
TABLE X (cont.) 
Mean Standard 
Time Period Difference Deviation p-va1ue 
T2o -17.83 77.14 0.440 
T2o.5 -15.92 73.42 0.468 
T21 -18.92 69.69 0.367 
T21.5 -8.08 69.73 0.696 
T22 -12.25 63.90 0.513 
T22.5 -15.33 65.33 0.433 
T23 -13.00 66.65 0.513 
T23.5 -10.58 63.17 0.573 
T24 -11.00 58.77 0.530 
T24.5 -9.50 55.98 0.569 
T25 -5.16 56.16 0.756 
DISCUSSION 
The results of this study show no statistically significant 
differences when comparing the effects of 2% xylocaine with or with-
out epinephrine on heart rate, systolic, or diastolic blood pressures 
during pedodontic procedures. This is in agreement with several of 
the investigators cited in the literature review (Wallace et al., 
1956, Cheraskin, 1958, and Elliot and Stein, 1974). They also agree 
with statements made by the New York Heart Association and in Accepted 
Dental Therapeutics. It must be mentioned, however, that no previous 
studies have used children as subjects. 
Several investigators (Barcroft, 1949, McCarthy, 1957, and Allen 
et al., 1973), nevertheless, report decreases in diastolic blood pres-
sure between 5 and 15 minutes after injection of an anesthetic solution 
with epinephrine. Figure I is a graph which relates all the parameters 
studied to each other on the same time scale. One can see a slight de-
crease, although statistically insignificant, in diastolic blood pres-
sure at 15 minutes after injection with epinephrine. This decrease 
may or may not be related to the decrease reported by the aforementioned 
investigators. 
Statistically significant decreases in heart rate during the later 
recording periods are evident in the results from both anesthetic solu-
tions. These can be explained by the child's loss of apprehension to 
the dental situation. 
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The significant increase in systolic blood pressure at 45 minutes 
after injection without epinephrine is probably attributed to the in-
efficiency and short duration of that solution. 
The GSR results show no significant differences between the two 
solutions at any time period from 1 minute before injection to 25 min-
utes after injection. One must realize, however, that statistically 
significant results are difficult to obtain when the standard devia-
tions are extremely large compared to the mean differences (Table X). 
Figure I, however, demonstrates some definite trends for the GSR. 
The peak (without epinephrine) at 30 seconds presents the possibility 
that there is more discomfort associated with an injection without 
epinephrine. This could be due to the immediate vasoconstricting 
properties when using a solution with epinephrine, tending to keep 
more anesthetic in the general area during and immediately following 
the injection. 
The curve without epinephrine remains more negative (thus, more 
stress, anxiety, or pain) from 6 minutes to 25 minutes. This can be 
explained by the reduced anesthetic efficiency of a solution without 
epinephrine (British Medical Journal, 1970; Gangarosa, 1967; and Bjorn 
and Hullet, 1947). In fact the peak at 15 minutes represents the need 
for reinjection of the solution without epinephrine which occurred in 
all but one case between 12 and 18 minutes after the original injection. 
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SUMMARY AND CONCLUSIONS 
Twelve children aged 4 to 10 were monitored for heart rate, 
blood pressure, and galvanic skin response during dental procedures 
involving maxillary infiltrations with 2% xylocaine hydrochloride 
with and without 1:100,000 epinephrine. No statistically significant 
differences between the two solutions were noted 5, 10, 15, 20, 30~ 
and 45 minutes after injection for heart rate, systolic, or diastolic 
blood pressures. 
The results from the GSR showed no significant differences be-
tween the two solutions due to the extremely large standard deviations 
encountered. However, certain observations and trends in the results 
tend to lead to the conclusion that the solution containing 1:100,000 
epinephrine is more comfortable and effective than the solution with-
out epinephrine when used for local dental anesthesia for children. 
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